Company intelligence / Profile preview

Beijing Sunho Pharmaceutical

Ownership: Private
Employees: ~800
Development stage: Other

Overview

Beijing Sunho Pharmaceutical is a leading Chinese pharmaceutical company specializing in contract development and manufacturing services for both small molecules and biologics. It has a robust clinical-stage pipeline focused on innovative immunotherapies for cancer. Six of its nine pipelines have reached clinical trials; three core products are in Phase 1/2 or NDA/BLA stages. The company also provides comprehensive CMC/CMO/CDMO services to global pharma clients.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Small moleculeMonoclonal antibodyFusion proteinNanobody therapyAntibody fusion proteins
Industry: Biotech

Drug pipeline

1 asset

compound digestive enzyme

Unknown

Partnerships

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Beyond the preview

Go deeper on Beijing Sunho Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Sunho Pharmaceutical.

Explore the full profile